Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review
Open accessThe DOI matches its Crossref record; 119 of the 121 references it cites were found in a registry or an index; 62 of the 229 sources its claims cite were checked for support.
Abstract
This review examines the effectiveness of various surgical and endoscopic bariatric interventions in improving several components of metabolic dysfunction-associated steatotic liver disease (MASLD). Roux-en-Y gastric bypass (RYGB) consistently showed substantial long-term reductions in liver fat, inflammation, and fibrosis, achieving resolution of steatosis in up to 95% of cases. Vertical sleeve gastrectomy (VSG) provided comparable hepatic benefits, significantly reducing liver fibrosis and steatosis in approximately 60% of patients. Adjustable gastric banding (AGB) demonstrated meaningful though comparatively modest hepatic improvements, with steatosis resolution in about 42% of patients. More aggressive procedures like biliopancreatic diversion with duodenal switch (BPD-DS) showed profound metabolic effects, though with increased nutritional risk. Endoscopic therapies, including intragastric balloon (IGB) and endoscopic sleeve gastroplasty (ESG), offered notable short- to medium-term hepatic improvements, significantly reducing steatosis and fibrosis markers. Newer therapies like duodenal mucosal resurfacing (DMR) and the duodenal-jejunal bypass liner showed promising preliminary results, warranting further investigation. Overall, surgical interventions remain superior for sustained liver health improvements, while endoscopic therapies present viable alternatives for patients requiring less invasive interventions.
Overview
CoChat Summary
TL;DR
This review synthesizes evidence on bariatric surgical and endoscopic interventions for MASLD/MASH, finding that surgery—especially RYGB—provides robust, durable hepatic improvements, while endoscopic therapies offer effective short-to-medium-term alternatives. RYGB achieved steatosis resolution in up to 95% of cases, VSG in about 60%, and AGB in about 42%, with endoscopic options reducing steatosis and fibrosis markers but requiring longer-term validation.
Key findings
- RYGB showed steatosis remission in 89–95% of patients, MASH severity reduction of 75–88.9%, and full MASH remission in 38%; one-year NASH resolution without fibrosis progression occurred in 56% versus 16% with lifestyle modification alone (p < 0.0001). ALT fell by 28.5% at 6 months, 45% at 1 year, and 61.3% over 3 years.
- VSG achieved NAFLD remission in 56% and steatosis remission in 56–68.4%; one cited study reported 100% MASH resolution. ALT decreased by 50% at 6 months (31.4 to 15.7 IU/L), and at 2 years VSG outperformed RYGB for ALT reduction (32.1% vs 15.4%).
- AGB produced steatosis resolution in about 42% and modest NAS improvement (35.3%); in a paired-biopsy study, NASH criteria fell from 64% preoperatively to ~11% at follow-up, and significant fibrosis (stage ≥2) dropped from 18 to 3 patients (p < 0.001).
- Endoscopic therapies showed short-to-medium-term benefits: IGB reduced NAS from 4 ± 2.25 to 2 ± 0.75 (p = 0.03) within 6 months and severe steatosis from 52% to 4% (p < 0.0001); ESG reduced NAFLD fibrosis score by 0.5 points, hepatic steatosis index by 4.85 points, and ALT by 6.32 U/L; DMR reduced ALT by 29.3% at 6 months; POSE 2.0 achieved complete steatosis resolution in 31.6% at 6 months and 52.6% at 12 months.
Methods
- Systematic search of PubMed, MEDLINE, and Google Scholar using keywords including “MASLD,” “MASH,” “NAFLD,” “NASH,” “obesity,” “bariatric surgery,” “Roux-en-Y gastric bypass,” “sleeve gastrectomy,” “endoscopic sleeve gastroplasty,” and “intragastric balloon.”
- Included randomized controlled trials, prospective and retrospective cohort studies, and meta-analyses examining liver histology, biochemical markers, liver enzymes, and non-invasive liver health assessments after intervention.
- Data on clinical outcomes, safety profiles, and procedural effectiveness were extracted and synthesized thematically by procedure type, intervention outcomes, and time frame; quality was assessed with the Newcastle–Ottawa Scale for observational studies and the Cochrane Risk of Bias tool for randomized controlled trials.
Limitations
- Stated: evidence for endoscopic and emerging therapies remains limited, with calls for longer-term and larger-scale studies; MAS evidence is limited by small sample sizes and absence of control groups; DJBL effects on fibrosis remain inconclusive; POSE long-term efficacy needs confirmation; DMR’s long-term role requires further study.
- Stated: BPD-DS carries risks of protein–calorie malnutrition, fat-soluble vitamin deficiencies, rare acute liver failure, and possible paradoxical fibrosis progression—one series found fibrosis worsened in 40% despite reduced steatosis.
- Evident: this is a review without pooled meta-analysis, relying on heterogeneous observational studies, small trials, and variable endpoints; several included findings are drawn from single studies or incomplete follow-up.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
53 Valid · 4 Not valid · 134 Not checked · 51 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Lifestyle modification, including diet and exercise, often leads to only modest and unsustained weight loss [11]”
§ Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review > 1. Introduction
What the sources say
- Partly supportedcites [11] Flore G. Preti A. Carta M.G. Deledda A. Fosci M. Nardi A.E. Loviselli A. Velluzzi F. Weight Maintenance after Dietary Weight Loss: Systematic Review and Meta-Analysis on the Effectiveness of Behavioural Intensive Intervention Nutrients 2022 14 1259 10.3390/nu14061259 35334917 PMC8953094 sourceExperimental — accuracy not yet measured
The Introduction (page not available) reports that only 25% of patients maintain weight loss long-term after a low-calorie diet, supporting the claim that weight loss is often unsustained. It also says combining exercise with diet produces better weight-loss outcomes than diet alone. The paper does not establish that weight loss from diet-and-exercise lifestyle modification is generally modest. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The proportion meeting NASH criteria fell from 64% pre-operatively to ~11% on follow-up”
§ Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review > 3. Results > 3.3. Adjustable Gastric Banding (AGB)
What the sources say
- Supportedcites [45] Dixon J.B. Bhathal P.S. Hughes N.R. O’Brien P.E. Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss Hepatology 2004 39 1647 1654 10.1002/hep.20251 15185306 source
The NASH Grade and Stage section reports 23 patients with NASH before surgery and four at follow-up. The Results section identifies 36 patients with paired biopsies, making those proportions 64% and approximately 11%. The Patients and Preoperative Assessment section confirms that the surgery was adjustable gastric banding; page numbers are unavailable in our copy. (LLM, conf=0.94)
plainstates a causen = 36- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“and the number of patients with significant fibrosis (stage ≥ 2) dropped from 18 to three (p < 0.001) [45].”
§ Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review > 3. Results > 3.3. Adjustable Gastric Banding (AGB)
What the sources say
- Supportedcites [45] Dixon J.B. Bhathal P.S. Hughes N.R. O’Brien P.E. Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss Hepatology 2004 39 1647 1654 10.1002/hep.20251 15185306 source
Table 4 (Discussion; page unavailable) gives fibrosis scores for 36 paired biopsies. Summing scores 2–4 yields 18 patients before weight loss and three at follow-up; the table reports P < 0.001 for the change in fibrosis scores. (LLM, conf=0.94)
plainstates a causen = 36 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In a landmark prospective trial, Verrastro and colleagues demonstrated that one year following RYGB surgery, resolution of non-alcoholic steatohepatitis (NASH) without progression of fibrosis occurred in 56% of patients compared to only 16% in patients managed by lifestyle modifications alone (p < 0.0001) [28].”
§ Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review > 3. Results > 3.1. Roux-en-Y Gastric Bypass (RYGB)
What the sources say
- Partly supportedcites [28] Verrastro O. Panunzi S. Castagneto-Gissey L. De Gaetano A. Lembo E. Capristo E. Guidone C. Angelini G. Pennestrì F. Sessa L. Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): A multicentre, open-label, randomised trial Lancet 2023 401 1786 1797 10.1016/S0140-6736(23)00634-7 37088093 sourceExperimental — accuracy not yet measured
The Results report 54 Roux-en-Y gastric bypass responders and 15 lifestyle-group responders; with 96 participants assigned to each group and missing one-year biopsies counted as non-responses in the Statistical analysis section, these correspond to 56% and 16%. The reported comparison is significant at p<0.0001. However, the comparator received lifestyle modification plus best medical care, not lifestyle modification alone. (LLM, conf=0.88)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, limited access and surgical risks have led to increased interest in endoscopic bariatric and metabolic therapies (EBMTs) such as endoscopic sleeve gastroplasty (ESG) and intragastric balloon (IGB) placement [19,20].”
§ Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review > 1. Introduction
What the sources say
- Not checked — no full text of the sourcecites [19] Sharaiha R.Z. Kumta N.A. Saumoy M. Desai A.P. Sarkisian A.M. Benevenuto A. Tyberg A. Kumar R. Igel L. Verna E.C. Endoscopic Sleeve Gastroplasty Significantly Reduces Body Mass Index and Metabolic Complications in Obese Patients Clin. Gastroenterol. Hepatol. 2017 15 504 510 10.1016/j.cgh.2016.12.012 28017845 source
- Partly supportedcites [20] Lee S.Y. Lai H. Chua Y.J. Wang M.X. Lee G.-H. Endoscopic Bariatric and Metabolic Therapies and Their Effects on Metabolic Syndrome and Non-alcoholic Fatty Liver Disease—A Systematic Review and Meta-Analysis Front. Med. 2022 9 880749 10.3389/fmed.2022.880749 PMC9124896 35615095 sourceExperimental — accuracy not yet measured
The Introduction says surgical risks and low uptake of bariatric surgery prompted the development of EBMTs, and it identifies ESG and IGB as examples. It does not say that limited access to surgery was a reason for the increased interest; low uptake among eligible patients is not the same as limited access. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
169 more claims · 36 with their cited sources checked
Create a free account to see all 242 claims and to verify the 11 references still open.
- Probably not a substantial claim. 10
- It may state two separate claims as one. 64
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review > 4. Discussion > 4.2. Fibrosis and Steatosis Improvement
“IGB reduced NAS by two points in six months, with 87% of patients achieving ≥ 3-point improvement [72,73].”
§ Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review > 3. Results > 3.5. Intragastric Balloon (IGB)
“a cohort study employing magnetic resonance elastography and liver biopsies found an 87% patient cohort experienced a median NAS reduction of three points, with 73% achieving reductions of at least two points [73].”
Citations
Cites
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Bariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800
Younossi, Z. M., Golabi, P., Paik, J. M., Henry, A., Van Dongen, C., & Henry, L. (2023) · Hepatology · doi:10.1097/hep.0000000000000004 · Cited by 3,383
Brauer, M., Roth, G. A., Aravkin, A. Y., Zheng, P., Abate, K. H., Abate, Y. H., Abbafati, C., Abbasgholizadeh, R., Abbasi, M. A., Abbasian, M., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00933-4 · Cited by 2,884
Biliopancreatic Diversion with a Duodenal Switch
Hess, D. S., & Hess, D. W. (1998) · Obesity Surgery · doi:10.1381/096089298765554476 · Cited by 1,040
Mason, E. E., & Ito, C. (1967) · Surgical Clinics of North America · doi:10.1016/s0039-6109(16)38384-0 · Cited by 931
Dombrowski, S. U., Knittle, K., Avenell, A., Araujo-Soares, V., & Sniehotta, F. F. (2014) · BMJ · doi:10.1136/bmj.g2646 · Cited by 816
Eisenberg, D., Shikora, S. A., Aarts, E., Aminian, A., Angrisani, L., Cohen, R. V., de Luca, M., Faria, S. L., Goodpaster, K. P. S., Haddad, A., et al. (2023) · Obesity Surgery · doi:10.1007/s11695-022-06332-1 · Cited by 768
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
Dixon, J. B., Bhathal, P. S., Hughes, N. R., & O'Brien, P. E. (2004) · Hepatology · doi:10.1002/hep.20251 · Cited by 727
Lassailly, G., Caiazzo, R., Ntandja-Wandji, L.-C., Gnemmi, V., Baud, G., Verkindt, H., Ningarhari, M., Louvet, A., Leteurtre, E., Raverdy, V., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.06.006 · Cited by 622
Bilio-pancreatic bypass for obesity: II. Initial experience in man
Scopinaro, N., Gianetta, E., Civalleri, D., Bonalumi, U., & Bachi, V. (1979) · Journal of British Surgery · doi:10.1002/bjs.1800660906 · Cited by 562
Laparoscopic adjustable gastric banding in the treatment of obesity: A systematic literature review
Chapman, A. (2004) · Surgery · doi:10.1016/s0039-6060(03)00392-1 · Cited by 529
Effect of bariatric surgery on nonalcoholic fatty liver disease: Systematic review and meta-analysis
Mummadi, R. R., Kasturi, K. S., Chennareddygari, S., & Sood, G. K. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.08.012 · Cited by 511
Life expectancy after bariatric surgery in the Swedish obese subjects study
Carlsson, L. M. S., Sjöholm, K., Jacobson, P., Andersson-Assarsson, J. C., Svensson, P.-A., Taube, M., Carlsson, B., & Peltonen, M. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002449 · Cited by 509
Pathophysiology of obesity and its associated diseases
Jin, X., Qiu, T., Li, L., Yu, R., Chen, X., Li, C., Proud, C. G., & Jiang, T. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.01.012 · Cited by 499
The Role of Obesity in Type 2 Diabetes Mellitus—An Overview
Chandrasekaran, P., & Weiskirchen, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031882 · Cited by 465
Li, L., Liu, D. ‐., Yan, H. ‐., Wang, Z. ‐., Zhao, S. ‐., & Wang, B. (2016) · Obesity Reviews · doi:10.1111/obr.12407 · Cited by 439
Cardiovascular risk and obesity
Cercato, C., & Fonseca, F. A. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0468-0 · Cited by 395
Aminian, A., Al-Kurd, A., Wilson, R., Bena, J., Fayazzadeh, H., Singh, T., Albaugh, V. L., Shariff, F. U., Rodriguez, N. A., Jin, J., et al. (2021) · JAMA · doi:10.1001/jama.2021.19569 · Cited by 375
Verrastro, O., Panunzi, S., Castagneto-Gissey, L., De Gaetano, A., Lembo, E., Capristo, E., Guidone, C., Angelini, G., Pennestrì, F., Sessa, L., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00634-7 · Cited by 362
Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis
Kral, J. G., Thung, S. N., Biron, S., Hould, F.-S., Lebel, S., Marceau, S., Simard, S., & Marceau, P. (2004) · Surgery · doi:10.1016/j.surg.2003.10.003 · Cited by 322
Leggio, M., Lombardi, M., Caldarone, E., Severi, P., D'Emidio, S., Armeni, M., Bravi, V., Bendini, M. G., & Mazza, A. (2017) · Hypertension Research · doi:10.1038/hr.2017.75 · Cited by 309
Abu Dayyeh, B. K., Rajan, E., & Gostout, C. J. (2013) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2013.04.197 · Cited by 279
Laparoscopic Adjustable Gastric Banding
Belachew, M., Legrand, M., Vincent, V., Lismonde, M., Docte, N. L., & Deschamps, V. (1998) · World Journal of Surgery · doi:10.1007/s002689900499 · Cited by 278
Sharaiha, R. Z., Kumta, N. A., Saumoy, M., Desai, A. P., Sarkisian, A. M., Benevenuto, A., Tyberg, A., Kumar, R., Igel, L., Verna, E. C., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.12.012 · Cited by 268
Fakhry, T. K., Mhaskar, R., Schwitalla, T., Muradova, E., Gonzalvo, J. P., & Murr, M. M. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.12.002 · Cited by 259
Caiazzo, R., Lassailly, G., Leteurtre, E., Baud, G., Verkindt, H., Raverdy, V., Buob, D., Pigeyre, M., Mathurin, P., & Pattou, F. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000945 · Cited by 226
Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery
Barker, K. B., Palekar, N. A., Bowers, S. P., Goldberg, J. E., Pulcini, J. P., & Harrison, S. A. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00419.x · Cited by 218
Rajagopalan, H., Cherrington, A. D., Thompson, C. C., Kaplan, L. M., Rubino, F., Mingrone, G., Becerra, P., Rodriguez, P., Vignolo, P., Caplan, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0383 · Cited by 216
Dixon, J., Bhathal, P., & O'Brien, P. (2006) · Obesity Surgery · doi:10.1381/096089206778663805 · Cited by 212
Effects of bariatric surgery on nonalcoholic fatty liver disease: Preliminary findings after 2 years
Furuya, C. K., De Oliveira, C. P. M. S., De Mello, E. S., Faintuch, J., Raskovski, A., Matsuda, M., Vezozzo, D. C. P., Halpern, A., Garrido, A. B., Alves, V. A. F., et al. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04833.x · Cited by 193
Updated position statement on sleeve gastrectomy as a bariatric procedure
(2012) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2012.02.001 · Cited by 184
Aspiration Therapy Leads to Weight Loss in Obese Subjects: A Pilot Study
Sullivan, S., Stein, R., Jonnalagadda, S., Mullady, D., & Edmundowicz, S. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.056 · Cited by 183
Søvik, T. T., Aasheim, E. T., Taha, O., Engström, M., Fagerland, M. W., Björkman, S., Kristinsson, J., Birkeland, K. I., Mala, T., & Olbers, T. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-5-201109060-00005 · Cited by 166
Long term outcomes of metabolic/bariatric surgery in adults
Courcoulas, A. P., Daigle, C. R., & Arterburn, D. E. (2023) · BMJ · doi:10.1136/bmj-2022-071027 · Cited by 164
Søvik, T. T., Taha, O., Aasheim, E. T., Engström, M., Kristinsson, J., Björkman, S., Schou, C. F., Lönroth, H., Mala, T., & Olbers, T. (2010) · Journal of British Surgery · doi:10.1002/bjs.6802 · Cited by 155
López-Nava, G., Bautista-Castaño, I., Jimenez, A., de Grado, T., & Fernandez-Corbelle, J. P. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.09.026 · Cited by 144
Kumar, N., Abu Dayyeh, B. K., Lopez-Nava Breviere, G., Galvao Neto, M. P., Sahdala, N. P., Shaikh, S. N., Hawes, R. H., Gostout, C. J., Goenka, M. K., Orillac, J. R., et al. (2018) · Surgical Endoscopy · doi:10.1007/s00464-017-5869-2 · Cited by 141
Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: Current and Potential Future Treatments
Sasaki, A., Nitta, H., Otsuka, K., Umemura, A., Baba, S., Obuchi, T., & Wakabayashi, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00164 · Cited by 133
Nelson, D. W., Blair, K. S., & Martin, M. J. (2012) · Archives of Surgery · doi:10.1001/archsurg.2012.1654 · Cited by 128
Subichin, M., Clanton, J., Makuszewski, M., Bohon, A., Zografakis, J. G., & Dan, A. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.06.015 · Cited by 124
Marinos, G., Eliades, C., Raman Muthusamy, V., & Greenway, F. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.03.005 · Cited by 123
Mingrone, G., van Baar, A. C., Devière, J., Hopkins, D., Moura, E., Cercato, C., Rajagopalan, H., Lopez-Talavera, J. C., White, K., Bhambhani, V., et al. (2022) · Gut · doi:10.1136/gutjnl-2020-323608 · Cited by 120
van Rijswijk, A.-S., van Olst, N., Schats, W., van der Peet, D. L., & van de Laar, A. W. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05394-x · Cited by 117
Surgical Treatment of Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease
Weiner, R. A. (2010) · Digestive Diseases · doi:10.1159/000282102 · Cited by 113
A history of intragastric balloons
Gleysteen, J. J. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.10.074 · Cited by 113
Effect of Bariatric Surgery on Liver Fibrosis
Moretto, M., Kupski, C., da Silva, V. D., Padoin, A. V., & Mottin, C. C. (2012) · Obesity Surgery · doi:10.1007/s11695-011-0559-y · Cited by 110
Forlano, R., Ippolito, A. M., Iacobellis, A., Merla, A., Valvano, M. R., Niro, G., Annese, V., & Andriulli, A. (2010) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2009.06.036 · Cited by 104
Nickel, F., Tapking, C., Benner, L., Sollors, J., Billeter, A. T., Kenngott, H. G., Bokhary, L., Schmid, M., von Frankenberg, M., Fischer, L., et al. (2018) · Obesity Surgery · doi:10.1007/s11695-017-3012-z · Cited by 100
Popov, V. B., Ou, A., Schulman, A. R., & Thompson, C. C. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.530 · Cited by 100
Barrichello, S., Hourneaux de Moura, D. T., Hourneaux de Moura, E. G., Jirapinyo, P., Hoff, A. C., Fittipaldi-Fernandez, R. J., Baretta, G., Felício Lima, J. H., Usuy, E. N., de Almeida, L. S., et al. (2019) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2019.06.013 · Cited by 100
Mottin, C. C., Moretto, M., Padoin, A. V., Kupski, C., Swarowsky, A. M., Glock, L., Duval, V., & da Silva, J. B. (2005) · Obesity Surgery · doi:10.1381/0960892054222830 · Cited by 97
Hajifathalian, K., Mehta, A., Ang, B., Skaf, D., Shah, S. L., Saumoy, M., Dawod, Q., Dawod, E., Shukla, A., Aronne, L., et al. (2021) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2020.08.023 · Cited by 96
Tai, C.-M., Huang, C.-K., Hwang, J.-C., Chiang, H., Chang, C.-Y., Lee, C.-T., Yu, M.-L., & Lin, J.-T. (2012) · Obesity Surgery · doi:10.1007/s11695-011-0579-7 · Cited by 91
Duodenal—Jejunal Bypass Sleeve: A Totally Endoscopic Device for the Treatment of Morbid Obesity
Gersin, K. S., Keller, J. E., Stefanidis, D., Simms, C. S., Abraham, D. D., Deal, S. E., Kuwada, T. S., & Heniford, B. T. (2007) · Surgical Innovation · doi:10.1177/1553350607312901 · Cited by 82
Kumar, N., Bazerbachi, F., Rustagi, T., McCarty, T. R., Thompson, C. C., Galvao Neto, M. P., Zundel, N., Wilson, E. B., Gostout, C. J., & Abu Dayyeh, B. K. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2636-3 · Cited by 81
Flore, G., Preti, A., Carta, M. G., Deledda, A., Fosci, M., Nardi, A. E., Loviselli, A., & Velluzzi, F. (2022) · Nutrients · doi:10.3390/nu14061259 · Cited by 80
Cazzo, E., Jimenez, L. S., Pareja, J. C., & Chaim, E. A. (2015) · Obesity Surgery · doi:10.1007/s11695-014-1489-2 · Cited by 72
Vargas, V., Allende, H., Lecube, A., Salcedo, M. T., Baena-Fustegueras, J. A., Fort, J. M., Rivero, J., Ferrer, R., Catalán, R., Pardina, E., et al. (2012) · World Journal of Hepatology · doi:10.4254/wjh.v4.i12.382 · Cited by 69
Short-, Mid- and Long-Term Results of Larrad Biliopancreatic Diversion
Larrad-Jiménez, Á., Sánchez-Cabezudo Díaz-Guerra, C., de Cuadros Borrajo, P., Bretón Lesmes, I., & Moreno Esteban, B. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9035-0 · Cited by 67
Endoscopic intestinal bypass creation by using self-assembling magnets in a porcine model
Ryou, M., Agoston, A. T., & Thompson, C. C. (2016) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2015.10.023 · Cited by 66
de Brito e Silva, M. B., Tustumi, F., de Miranda Neto, A. A., Dantas, A. C. B., Santo, M. A., & Cecconello, I. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05412-y · Cited by 66
Mahamat‐Saleh, Y., Aune, D., Freisling, H., Hardikar, S. S., Jaafar, R. F., Rinaldi, S., Gunter, M. J., & Dossus, L. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02857-7 · Cited by 65
Baldwin, D., Chennakesavalu, M., & Gangemi, A. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.09.060 · Cited by 57
Keshishian, A., Zahriya, K., & Willes, E. B. (2005) · Obesity Surgery · doi:10.1381/096089205774859290 · Cited by 57
van Baar, A. C. G., Beuers, U., Wong, K., Haidry, R., Costamagna, G., Hafedi, A., Deviere, J., Ghosh, S. S., Lopez-Talavera, J. C., Rodriguez, L., et al. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.10.006 · Cited by 55
Laparoscopic Sleeve Gastrectomy Resolves NAFLD: Another Formal Indication for Bariatric Surgery?
Esquivel, C. M., Garcia, M., Armando, L., Ortiz, G., Lascano, F. M., & Foscarini, J. M. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3466-7 · Cited by 51
Modified primary obesity surgery endoluminal (POSE-2) procedure for the treatment of obesity
López-Nava, G., Asokkumar, R., Arau, R. T., Neto, M. G., & Dayyeh, B. A. (2020) · VideoGIE · doi:10.1016/j.vgie.2019.11.010 · Cited by 50
Vantanasiri, K., Matar, R., Beran, A., & Jaruvongvanich, V. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04522-3 · Cited by 49
Cherla, D. V., Rodriguez, N. A., Vangoitsenhoven, R., Singh, T., Mehta, N., McCullough, A. J., Brethauer, S. A., Schauer, P. R., & Aminian, A. (2020) · Surgical Endoscopy · doi:10.1007/s00464-019-07017-0 · Cited by 46
Chandan, S., Mohan, B. P., Khan, S. R., Facciorusso, A., Ramai, D., Kassab, L. L., Bhogal, N., Asokkumar, R., Lopez-Nava, G., McDonough, S., et al. (2021) · Obesity Surgery · doi:10.1007/s11695-020-05084-0 · Cited by 46
Schlottmann, F., Ryou, M., Lautz, D., Thompson, C. C., & Buxhoeveden, R. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05554-z · Cited by 44
Effect of intragastric balloons on liver enzymes: A systematic review and meta-analysis
Popov, V. B., Thompson, C. C., Kumar, N., Ciarleglio, M. M., Deng, Y., & Laine, L. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4178-2 · Cited by 43
de Jonge, C., Rensen, S. S., Koek, G. H., Joosten, M. F., Buurman, W. A., Bouvy, N. D., & Greve, J. W. M. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.07.029 · Cited by 43
Jimenez, L. S., Mendonça Chaim, F. H., Mendonça Chaim, F. D., Utrini, M. P., Gestic, M. A., Chaim, E. A., & Cazzo, E. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3286-9 · Cited by 43
Jagtap, N., Kalapala, R., Katakwar, A., Sharma, M., Aslam, M., Gupta, R., Rao, P. N., Goud, R., Tandan, M., Kanakagiri, H., et al. (2021) · Indian Journal of Gastroenterology · doi:10.1007/s12664-021-01202-7 · Cited by 43
Gollisch, K., Lindhorst, A., & Raddatz, D. (2016) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0042-118961 · Cited by 42
Nunes, B. C. M., de Moura, D. T. H., Kum, A. S. T., de Oliveira, G. H. P., Hirsch, B. S., Ribeiro, I. B., Gomes, I. L. C., de Oliveira, C. P. M., Mahmood, S., Bernardo, W. M., et al. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06747-4 · Cited by 41
Loy, J. J., Youn, H. A., Schwack, B., Kurian, M., Ren Fielding, C., & Fielding, G. A. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.11.010 · Cited by 39
Endoscopic intragastric balloon: a gimmick or a viable option for obesity?
Claudia Gollisch, K. S., & Raddatz, D. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2019.09.67 · Cited by 37
Schwenger, K. J. P., Fischer, S. E., Jackson, T., Okrainec, A., & Allard, J. P. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.06.007 · Cited by 36
Non-alcoholic fatty liver disease resolution following sleeve gastrectomy
Algooneh, A., Almazeedi, S., Al-Sabah, S., Ahmed, M., & Othman, F. (2016) · Surgical Endoscopy · doi:10.1007/s00464-015-4426-0 · Cited by 36
Abad, J., Llop, E., Arias-Loste, M. T., Burgos-Santamaría, D., Martínez Porras, J. L., Iruzubieta, P., Graus, J., Ruiz-Antorán, B., Sánchez Yuste, M. R., Romero-Gómez, M., et al. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.10.027 · Cited by 35
Phillips, M. L., Boase, S., Wahlroos, S., Dugar, M., Kow, L., Stahl, J., Slavotinek, J. P., Valentine, R., Toouli, J., & Thompson, C. H. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00793.x · Cited by 34
Silva, L. B., & Neto, M. G. (2022) · Minimally Invasive Therapy & Allied Technologies · doi:10.1080/13645706.2021.1874420 · Cited by 32
Effect of Aspiration Therapy on Obesity-Related Comorbidities: Systematic Review and Meta-Analysis
Jirapinyo, P., de Moura, D. T. H., Horton, L. C., & Thompson, C. C. (2020) · Clinical Endoscopy · doi:10.5946/ce.2019.181 · Cited by 32
Russo, M. F., Lembo, E., Mari, A., Angelini, G., Verrastro, O., Nanni, G., Pompili, M., Raffaelli, M., Vecchio, F. M., Bornstein, S. R., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa892 · Cited by 28
Various Intragastric Balloons Under Clinical Investigation
Choi, S. J., & Choi, H. S. (2018) · Clinical Endoscopy · doi:10.5946/ce.2018.140 · Cited by 28
Nguyen, V., Li, J., Gan, J., Cordero, P., Ray, S., Solis-Cuevas, A., Khatib, M., & Oben, J. A. (2017) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2017/4697194 · Cited by 28
Aspiration Therapy for Obesity
Sullivan, S. A. (2017) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2016.12.001 · Cited by 28
Endoscopic therapies for patients with obesity: A systematic review and meta-analysis
Weitzner, Z. N., Phan, J., Begashaw, M. M., Mak, S. S., Booth, M. S., Shekelle, P. G., Maggard-Gibbons, M., & Girgis, M. D. (2023) · Surgical Endoscopy · doi:10.1007/s00464-023-10390-6 · Cited by 27
Effect of the EndoBarrier Device: a 4-Year Follow-up of a Multicenter Randomized Clinical Trial
van Rijn, S., Roebroek, Y. G. M., de Jonge, C., Greve, J. W. M., & Bouvy, N. D. (2019) · Obesity Surgery · doi:10.1007/s11695-018-03659-6 · Cited by 27
Karlas, T., Petroff, D., Feisthammel, J., Beer, S., Blüher, M., Schütz, T., Lichtinghagen, R., Hoffmeister, A., & Wiegand, J. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06150-5 · Cited by 26
Platelet Counts and Liver Enzymes after Bariatric Surgery
Johansson, H.-E., Haenni, A., & Zethelius, B. (2013) · Journal of Obesity · doi:10.1155/2013/567984 · Cited by 25
Gagner, M., Almutlaq, L., Cadiere, G.-B., Torres, A. J., Sanchez-Pernaute, A., Buchwald, J. N., & Abuladze, D. (2024) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2023.10.018 · Cited by 24
Endoscopic bariatrics: current therapies and future directions
Reja, D., Zhang, C., & Sarkar, A. (2022) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2020.03.09 · Cited by 24
AlKhatry, M., Rapaka, B., Maselli, D. B., Abboud, D. M., Brunaldi, V. O., Mahmoud, T., Ghazi, R., Abdul Razzak, F., Gala, K., Joudah, I., et al. (2023) · Endoscopy · doi:10.1055/a-2117-6274 · Cited by 23
Micronutrient status 2 years after bariatric surgery: a prospective nutritional assessment
Côté, M., Pelletier, L., Nadeau, M., Bouvet-Bouchard, L., Julien, F., Michaud, A., Biertho, L., & Tchernof, A. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1385510 · Cited by 19
Roehlen, N., Laubner, K., Nicolaus, L., Schwacha, H., Bettinger, D., Krebs, A., Thimme, R., & Seufert, J. (2022) · Nutrition · doi:10.1016/j.nut.2022.111806 · Cited by 17
Ren, M., Zhou, X., Yu, M., Cao, Y., Xu, C., Yu, C., & Ji, F. (2023) · Digestive Endoscopy · doi:10.1111/den.14409 · Cited by 17
Frenken, M., Cho, E. Y., Karcz, W. K., Grueneberger, J., & Kuesters, S. (2011) · Journal of Obesity · doi:10.1155/2011/860169 · Cited by 17
Riedel, N., Laubner, K., Lautenbach, A., Schön, G., Schlensak, M., Stengel, R., Eberl, T., Dederichs, F., Aberle, J., & Seufert, J. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.02.029 · Cited by 15
Lee, S.-Y., Lai, H., Chua, Y. J., Wang, M. X., & Lee, G.-H. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.880749 · Cited by 14
Zadeh, M. H., Zamaninour, N., Ansar, H., Kabir, A., Pazouki, A., & Farsani, G. M. (2021) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2021.00065.r1.1504221 · Cited by 14
Dziakova, J., Torres, A., Odovic, M., Esteban, J. M., Vázquez-Romero, M., Castillo, A., Sánchez-Pernaute, A., & Gagner, M. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07432-w · Cited by 13
Azulai, S., Grinbaum, R., Beglaibter, N., Eldar, S. M., Rubin, M., Ben-Haroush Schyr, R., Romano-Zelekha, O., & Ben-Zvi, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10051144 · Cited by 13
Ren, M., Zhou, X., Lv, L., & Ji, F. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00448 · Cited by 12
Laparoscopic adjustable gastric banding
Beitner, M., & Kurian, M. S. (2012) · Abdominal Radiology · doi:10.1007/s00261-012-9864-8 · Cited by 11
Rothstein, R. I., Kopjar, B., Woodman, G. E., Swain, J. M., de la Cruz-Muñoz, N., Kushnir, V. M., Pryor, A. D., English, W. J., Odstrcil, E. A., & Sullivan, S. (2024) · Techniques and Innovations in Gastrointestinal Endoscopy · doi:10.1016/j.tige.2023.10.002 · Cited by 11
Effect on Liver Enzymes of Biliopancreatic Diversion: 4 Years of Follow-Up
Aller, R., Pacheco, D., Izaola, O., Primo, D., & de Luis, D. A. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000375506 · Cited by 10
Liver failure following biliopancreatic diversions: a narrative review
Cazzo, E., Pareja, J. C., & Chaim, E. A. (2016) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2016.0129220616 · Cited by 9
Yu, H.-H., Hsieh, M.-C., Wu, S.-Y., Sy, E. D., & Shan, Y.-S. (2019) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s190631 · Cited by 9
The Effect of Laparoscopic Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease
Batman, B., Altun, H., Simsek, B., Aslan, E., & Namli Koc, S. (2019) · Surgical Laparoscopy, Endoscopy & Percutaneous Techniques · doi:10.1097/sle.0000000000000672 · Cited by 9
Comparison of different liver fibrosis scores following sleeve gastrectomy
Alexander, H., Falk, R., Utz, S., Felix, D., Aladdin, A. D., Hermann, K., Laura, S., Johanna, B., & Michael, A. (2025) · Langenbeck's Archives of Surgery · doi:10.1007/s00423-024-03569-5 · Cited by 8
van Berckel, M. M. G., van Loon, S. L. M., Boer, A.-K., Scharnhorst, V., & Nienhuijs, S. W. (2021) · Obesity Facts · doi:10.1159/000510401 · Cited by 4
Norouzian Ostad, A., Rajabzadeh, F., Jamialahmadi, T., Goshayeshi, L., Ranjbar, G., Rezvani, R., Nematy, M., & Jangjoo, A. (2023) · Updates in Surgery · doi:10.1007/s13304-022-01421-3 · Cited by 4
Chen, H.-Y., Yang, P.-J., Lee, P.-C., Chuang, P.-H., Yang, Y.-H., Chiu, W.-T., & Wu, C.-H. (2024) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2024.02.018 · Cited by 4
Bazerbachi, F., Vargas, E. J., Mounajjed, T., Venkatesh, S. K., Watt, K. D., Port, J. D., Basu, R., Rizk, M., Acosta, A., Hanouneh, I., et al. (2018) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.04.1309 · Cited by 4
Research works printed but not linked: 1
- Mitchell B.G. Collier S.A. Gupta N. Roux-en-Y Gastric Bypass StatPearls Publishing Treasure Island, FL, USA 2025 31985950
Cited by
Relevance of lipid droplets in metabolic dysfunction-associated steatotic liver disease
Weiskirchen, R., & Lonardo, A. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2671694 · Cited by 9
Yodoshi, T., Ollberding, N. J., McNeill, M., Ley, S. L., Kirk, S., Kleiner, D. E., Arce‐Clachar, A. C., Bramlage, K., Inge, T. H., Helmrath, M. A., et al. (2026) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70766 · Cited by 7
Herdiana, Y. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s562536 · Cited by 4
Grama, P., Ciorba, M., Popa, S., Ismaiel, A., & Bataga, S. M. (2026) · Metabolites · doi:10.3390/metabo16080536 · Cited by 1
Onoiu, A.-I., Murray, L., Gerardin, Y., Singh, G., Egger, R., González-Serrano, S., Cambra-Cortés, V., Jiménez-Franco, A., Guilarte, C., Parada, D., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8725050/v1 · Cited by 1
Metadata
- Authors
- Tasabehji, D., Saleh, S., & Mokadem, M.
- Affiliations
- University of Iowa (US)
- Corresponding author
- Mokadem, Mohamad
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2025-06-06
- Volume
- 14
- Issue
- 12
- Pages
- 4012
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC12194630
- OpenAlex
- W4411101122
- Semantic Scholar
- bb5a3823e743358bcf141105843a5d1e6b20511e
- Cited by
- 14
- References
- 121
- Citations by year
- 2026: 11 · 2025: 3
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- US Department of Veterans Affairs (I01 BX004774-05)
- VA Merit Review Program (I01 BX004774-05)
- Department Internal Medicine at University of Iowa Carver College of Medicine (I01 BX004774-05)
- University of Iowa Fraternal Order of Eagles Diabetes Research Center (I01 BX004774-05)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
- Keywords
- non-alcoholic fatty liver disease, bariatric surgery, endoscopic treatment, Roux-en-Y gastric bypass, sleeve gastrectomy, gastric banding, biliopancreatic diversion with duodenal switch, intragastric balloon, endoscopic sleeve gastroplasty, duodenal mucosal resurfacing, duodenal-jejunal bypass liner, hepatic steatosis, liver fibrosis, liver inflammation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.